Mingyang Li
- Cancer Research top 2%
- MicroRNA in disease regulation 16
- Cancer-related molecular mechanisms research 13
- Genetics top 2%
- Glioma Diagnosis and Treatment 26
- Molecular Biology top 5%
- Epigenetics and DNA Methylation 23
- Cancer-related gene regulation 12
- Materials Chemistry top 5%
- Biochemistry top 5%
-
- Total Knee Arthroplasty Outcomes 19
-
- Plant Molecular Biology Research 17
-
- Ferroptosis and cancer prognosis 16
Mingyang Li
317 papers receiving 5.1k citations
Peers
Comparison fields: 5 of 158
- Cancer Research 721
- Genetics 403
- Molecular Biology 2.1k
- Materials Chemistry 1.1k
- Biochemistry 128
Countries citing papers authored by Mingyang Li
This map shows the geographic impact of Mingyang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mingyang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mingyang Li more than expected).
Fields of papers citing papers by Mingyang Li
This network shows the impact of papers produced by Mingyang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mingyang Li. The network helps show where Mingyang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Mingyang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 2 | |
| 2 | 2024 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2023 | 13 | |
| 5 | 2023 | 3 | |
| 6 | 2023 | 3 | |
| 7 | 2023 | 1 | |
| 8 | 2023 | 1 | |
| 9 | 2023 | 11 | |
| 10 | 2023 | 5 | |
| 11 | 2021 | 34 | |
| 12 | 2020 | 23 | |
| 13 | Methyl-CpG-binding domain 3 (Mbd3) is an important regulator for apoptosis in mouse embryonic stem cells. | 2020 | 4 |
| 14 | 2020 | 18 | |
| 15 | 2019 | 4 | |
| 16 | 2016 | 8 | |
| 17 | Cloning and Expression Analysis of a Late Embryogenesis Abundant Protein Gene CpLEA from Chimonanthus praecox | 2014 | 3 |
| 18 | 2010 | 13 | |
| 19 | Polyploidy induction and identification in Lilium formosanum × Lilium longiflorum var. scabrum. | 2009 | 2 |
| 20 | Development of real-time reverse-transcription PCR for detection of mesogenic and virulent Newcastle disease virus RNA | 2007 | 1 |
About Mingyang Li
Mingyang Li is a scholar working on Genetics, Cancer Research and Molecular Biology, having authored 336 papers that have together received 5.2k indexed citations. Recurring topics across this work include Glioma Diagnosis and Treatment (26 papers), Epigenetics and DNA Methylation (23 papers), Total Knee Arthroplasty Outcomes (19 papers), Plant Molecular Biology Research (17 papers), MicroRNA in disease regulation (16 papers), Ferroptosis and cancer prognosis (16 papers), Cancer-related molecular mechanisms research (13 papers) and Cancer-related gene regulation (12 papers). The work is most often cited by research in Cancer Research (721 citations), Genetics (403 citations) and Molecular Biology (2.1k citations). Mingyang Li has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lain‐Jong Li, Hsiang‐Lin Liu, Chang-Lung Hsu, Chih-Chiang Shen, Yi Zeng, Yanwei Liu, Bin Shen, Chuanbao Zhang, Ming‐Hui Chiu and Shunzhao Sui. Their work appears in journals such as PLoS ONE, International Journal of Molecular Sciences, Scientific Reports, Pathology - Research and Practice and HortScience.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.